Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €31.85 EUR
Change Today +0.223 / 0.71%
Volume 0.0
As of 10:06 AM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

korian-medica (KO2) Snapshot

Open
€31.63
Previous Close
€31.63
Day High
€31.85
Day Low
€31.58
52 Week High
03/25/15 - €35.00
52 Week Low
08/11/14 - €25.43
Market Cap
2.5B
Average Volume 10 Days
18.2
EPS TTM
--
Shares Outstanding
79.0M
EX-Date
07/1/15
P/E TM
--
Dividend
€0.60
Dividend Yield
1.88%
Current Stock Chart for KORIAN-MEDICA (KO2)

Related News

No related news articles were found.

korian-medica (KO2) Related Businessweek News

No Related Businessweek News Found

korian-medica (KO2) Details

Korian-Medica provides temporary and permanent dependency care services in France, Germany, Belgium, and Italy. As of April 30, 2014, it managed 506 nursing homes; and 87 specialised post-acute care clinics, which has approximately 2,400 beds in intermediate residences, as well as provides homecare and residences services. The company also operates retirement homes, médicalisées, and rehabilitation and psychiatric clinics. Korian-Medica was founded in 2001 and is based in Paris, France.

37,782 Employees
Last Reported Date: 04/29/15
Founded in 2001

korian-medica (KO2) Top Compensated Officers

Chief Executive Officer
Total Annual Compensation: €1.0M
Compensation as of Fiscal Year 2014.

korian-medica (KO2) Key Developments

Korian-Medica Announces Unaudited Consolidated Revenue Results for the First Quarter Ended March 31, 2015

Korian-Medica announced unaudited consolidated revenue results for the first quarter ended March 31, 2015. For the quarter, the company reported revenue of EUR 628.0 million compared to EUR 347.2 million a year ago. Proforma revenue was EUR 628.0 million compared to EUR 611.1 million a year ago.

Korian-Medica Proposes Dividend for Financial Year 2014, Payable on July 24, 2015

Korian-Medica proposed at its AGM to be held on June 25, 2015, the payment of a dividend for financial year 2014 of €0.60 per share. Record date is June 30, 2015. Ex date is July 1, 2015. The dividend is payable on July 24, 2015.

Korian-Medica Announces Board Changes

Pursuant to the commitments undertaken upon the merger between Korian and Medica completed on 18 March 2014, Mr. Jacques Bailet retired from his positions of Member and Chairman of the Board of Directors of Korian-Medica. Mr. Christian Chautard, who held the position of Vice-Chairman of the Board of Directors since 18 March 2014, was appointed as Chairman of the Board of Directors in place of Mr. Jacques Bailet. Mr. Christian Chautard was Chairman of the Supervisory Board, and then of the Board of Directors of Korian from December 2011 until the date of the merger with Medica.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KO2:GR €31.85 EUR +0.223

KO2 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Generale de Sante SA €14.80 EUR +0.01
Le Noble Age €20.42 EUR +0.07
Maternus-Kliniken AG €1.31 EUR +0.062
Orpea €66.66 EUR +0.93
RHOEN-KLINIKUM AG €25.45 EUR -0.254
View Industry Companies
 

Industry Analysis

KO2

Industry Average

Valuation KO2 Industry Range
Price/Earnings 32.2x
Price/Sales 1.0x
Price/Book 1.2x
Price/Cash Flow 14.1x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KORIAN-MEDICA, please visit www.groupe-korian.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.